HAVCR2 and autoimmune hepatitis: described a lower frequency of TIM-3 positive T cells together with increased IL-17 levels in patients suffering from autoimmune hepatitis, and experiments on mice confirmed that the blockade of TIM-3 signaling aggravated liver injury (120).